Guia Covid-19

COVID-19

Interview

Linamara Rizzo Battistella: In defense of movement

The physician who helped establish Brazil's policy on the rights of people with disabilities now fights to rehabilitate Covid-19 patients

By and

COVID-19

Limited use

ANVISA authorizes the use of three COVID-19 drugs, but they are expensive and designed only for specific situations

By

COVID-19

Severe illness in children

A rare syndrome linked to the novel coronavirus causes lesions in multiple organs

By

COVID-19

Focus on the genome

Brazil is still behind in monitoring Sars-CoV-2 genetics, but an injection of funding for research networks and the acquisition of materials could improve the situation

By

COVID-19

In real time

Academic initiatives are collecting personal accounts of memories and mourning experienced during the pandemic

By

COVID-19

All eyes on ButanVac

New vaccine candidate uses a more stable version of the spike protein

By

COVID-19

Patent waivers under debate

Suspending intellectual property rights for vaccines needs to overcome technology and production hurdles if it is to be successful

By

Cover

Education at risk

Prolonged school closings and unequal access to distance learning is causing increased student dropouts and learning-acquisition gaps

By

COVID-19

Complex choices

Bioethics committees have become increasingly important in solving dilemmas brought about by the pandemic, but few hospitals have them

By

COVID-19

A town turned laboratory

Epidemiological studies, such as the one led in the town of Serrana, São Paulo, should provide valuable information about the pandemic

By

COVID-19

New vaccines on the way

Butantan Institute and federal government plan to start human trials of two vaccine candidates in the coming months

By and

COVID-19

The evolution of a virus

Low vaccination rates and lack of control over SARS-CoV-2 circulation is increasing the likelihood that more transmissible and lethal variants will emerge

By

Research during quarantine

Research during quarantine

Fernando Carvall“It is considered normal that of 100,000 deaths, the majority are black” I study racial inequality and the mortality of cervical and breast cancer. Cervical cancer is an infectious disease whose incidence is strongly linked to a lack of access to preventive therapies, which is why it is associated with poverty and inequality and... View Article

By

INTERVIEW

Eurico Arruda: Admirer of viruses

Coronavirus specialist and USP physician speaks about the new variants of SARS-CoV-2 and the risk they represent in the efficacy of some vaccines

By

Covid-19

The expected effect of vaccines

Administering vaccines on a large scaled will tell us whether, in addition to protecting against the disease, they are also able to prevent infection by SARS-CoV-2

By

Covid-19

Breathless emerging economies

Lack of public and private investment heightens the dependence of Brazil and South Africa on vaccines from other countries, unlike the other BRICS members

By

Covid-19

Obstacle course

Research centers working on vaccines for the novel coronavirus in Brazil face major hurdles

By

Covid-19

Combat strategy

Research networks seeking to strengthen dialogue with the public authorities arise in response to the pandemic

By

INTERVIEW

Dimas Covas: The trajectory of Butantan

The hematologist from USP readies the São Paulo institute to fight the pandemic and has plans to transform it into one of the world’s top producers of vaccines and serums

By and

COVID-19

vaccine. Now what?

The introduction of vaccines in the battle against the COVID-19 pandemic raises new challenges

By

COVID-19

A more balanced game

Approved for emergency use, CoronaVac is the first vaccine to be offered in Brazil

By

COVID-19

The mutation risk

New strains of SARS-Cov-2, such as the one identified in the United Kingdom in December, could make the pathogen more transmissible and virulent

By

COVID-19

The era of genetic vaccines

The vaccines from BioNTech/Pfizer and Moderna result from historical investments in messenger RNA technology leading to the creation of new products

By

COVID-19

Distribution challenges

Governments need to work with pharmaceutical and logistics companies to overcome obstacles to start the SARS-CoV-2 immunization campaign

By

COVID-19

Approval strategy

Amid uncertainty, São Paulo announces state vaccination plan

By

Research during the quarantine

“When I woke up, it was wonderful to realize that I was still alive.”

I was infected by the novel coronavirus in late February, while attending two scientific conferences—one in Lisbon and another in Jerusalem. Both had many participants and took place at the beginning of the COVID-19 pandemic. I returned to São Paulo on March 5th. On the 8th, I attended the release of my biography, called Não,... View Article

By

Research during the quarantine

“I began valuing my personal relationships more during the pandemic”

Oceanographic research is heavily dependent on fieldwork and, to a large extent, on laboratory and on-board work. In March, with the prospect of a lockdown looming on the horizon, activities at USP [University of São Paulo] were suspended, as well as our field trips. This was the main impact of the pandemic on my work... View Article

By

COVID-19

Welcome voices

Pandemic leads to greater communication between doctors, scientists, and the general public

By

COVID-19

The pandemic detectives

Health professionals use a variety of methods and instruments to follow the trail of the novel coronavirus and to try to contain the epidemic

By

COVID-19

Back to school?

Obstacles to resuming classroom teaching caused by the worsening pandemic, problems with mass testing, and behavior outside school

By